These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Rivastigmine treatment as an add-on to antipsychotics in patients with schizophrenia and cognitive deficits. Chouinard S; Stip E; Poulin J; Melun JP; Godbout R; Guillem F; Cohen H Curr Med Res Opin; 2007 Mar; 23(3):575-83. PubMed ID: 17355738 [TBL] [Abstract][Full Text] [Related]
24. Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia. Malhi GS; Ivanovski B; Hadzi-Pavlovic D; Mitchell PB; Vieta E; Sachdev P Bipolar Disord; 2007; 9(1-2):114-25. PubMed ID: 17391355 [TBL] [Abstract][Full Text] [Related]
26. Critical evaluation of cognitive dysfunctions as endophenotypes of schizophrenia. Kéri S; Janka Z Acta Psychiatr Scand; 2004 Aug; 110(2):83-91. PubMed ID: 15233708 [TBL] [Abstract][Full Text] [Related]
27. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. Green MF J Clin Psychiatry; 2006 Oct; 67(10):e12. PubMed ID: 17107235 [TBL] [Abstract][Full Text] [Related]
28. Cognitive impairment in schizophrenia: a life span perspective. O'Donnell BF Am J Alzheimers Dis Other Demen; 2007; 22(5):398-405. PubMed ID: 17959875 [TBL] [Abstract][Full Text] [Related]
29. Cognitive impairment in schizophrenia is the core of the disorder. Elvevåg B; Goldberg TE Crit Rev Neurobiol; 2000; 14(1):1-21. PubMed ID: 11253953 [TBL] [Abstract][Full Text] [Related]
30. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up. Tabarés-Seisdedos R; Balanzá-Martínez V; Sánchez-Moreno J; Martinez-Aran A; Salazar-Fraile J; Selva-Vera G; Rubio C; Mata I; Gómez-Beneyto M; Vieta E J Affect Disord; 2008 Aug; 109(3):286-99. PubMed ID: 18289698 [TBL] [Abstract][Full Text] [Related]
31. Cognitive impairment associated with schizophrenia: a review of the humanistic burden. Kitchen H; Rofail D; Heron L; Sacco P Adv Ther; 2012 Feb; 29(2):148-62. PubMed ID: 22351433 [TBL] [Abstract][Full Text] [Related]
32. [Psychophysiology of schizophrenic disorders of attention--concepts, findings and working hypotheses]. Ulrich G; Gaebel W Fortschr Neurol Psychiatr; 1987 Sep; 55(9):279-88. PubMed ID: 3311950 [TBL] [Abstract][Full Text] [Related]
33. Assessing cognitive impairment in patients with schizophrenia. Schulz SC; Murray A J Clin Psychiatry; 2016 Feb; 77 Suppl 2():3-7. PubMed ID: 26919051 [TBL] [Abstract][Full Text] [Related]
34. Negative symptoms and cognitive deficits: what is the nature of their relationship? Harvey PD; Koren D; Reichenberg A; Bowie CR Schizophr Bull; 2006 Apr; 32(2):250-8. PubMed ID: 16221995 [TBL] [Abstract][Full Text] [Related]
36. Cognitive and functional deficits in people with schizophrenia: Evidence for accelerated or exaggerated aging? Harvey PD; Rosenthal JB Schizophr Res; 2018 Jun; 196():14-21. PubMed ID: 28506706 [TBL] [Abstract][Full Text] [Related]
37. What do we know about neuropsychological aspects of schizophrenia? Palmer BW; Dawes SE; Heaton RK Neuropsychol Rev; 2009 Sep; 19(3):365-84. PubMed ID: 19639412 [TBL] [Abstract][Full Text] [Related]
38. [Remarks regarding disorders of cognitive functions in the pathomechanism of schizophrenia]. Czerwiński A Psychiatr Pol; 1980; 14(1):59-62. PubMed ID: 7367520 [No Abstract] [Full Text] [Related]
39. Turning it upside down: areas of preserved cognitive function in schizophrenia. Gold JM; Hahn B; Strauss GP; Waltz JA Neuropsychol Rev; 2009 Sep; 19(3):294-311. PubMed ID: 19452280 [TBL] [Abstract][Full Text] [Related]
40. The effects of aging on insight into illness in schizophrenia: a review. Gerretsen P; Plitman E; Rajji TK; Graff-Guerrero A Int J Geriatr Psychiatry; 2014 Nov; 29(11):1145-61. PubMed ID: 25055980 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]